 
            IndraLab
Statements
USP7 activates Osteoporosis. 4 / 4
                        
    
      
      
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
      
    
      
      
        |
        
      
      
        
          
          2
          
        
      
        
      
        
          
          2
          
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
      
    
  
                      
                    
                                      reach
                                
                                  
                                
                                
          
          
                                  "We demonstrate that USP7 promotes the differentiation of CD14+ PBMCs into osteoclasts via HMGB1 deubiquitination and that inhibition of USP7 effectively attenuates bone loss in osteoporosis in vivo.The translational potential of this article:The study reveals novel insights into the role of USP7 in the progression of osteoporosis and provides a new therapeutic target for the treatment of osteoporosis."